Birge Berns

Birge is VP Head of Clinical Development & Regulatory Strategy at tranScrip. She is a global project leader and pharmaceutical physician with a broad background in clinical medicine, oncology and rheumatology/immunology, and a special interest in healthcare innovation.

Birge has more than 30 years’ experience in global R&D, spanning all aspects of early and late drug development, including strategic, clinical, regulatory and market access. She has worked in senior leadership roles in pharma companies including Sanofi Aventis and Johnson&Johnson, covering both small and large molecules in a range of therapeutic areas, driving cross-functional global teams and integrating teams across organisations.

At tranScrip, Birge has been applying her leadership skills and broad clinical and regulatory R&D experience to a wide variety of projects in early and later phases of development.

Birge received her medical qualification and MD from the University of Erlangen/Nürnberg, Germany. She gained her clinical training in general medicine/rheumatology and oncology in the UK National Health Service. She subsequently gained 2 separate Masters degrees in oncology and pharmaceutical medicine and maintains academic links with the Faculty of Pharmaceutical Medicine (FPM), Institute of Cancer Research (ICR), London and Imperial College Business School, London.